Clinical Trials Browser

Withdrawn × Interventional × Neoplastic Cells, Circulating × Clear all

NCT04648189 2023-10-19

Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC

Phase 2 Withdrawn

Lung Neoplasms, Neoplastic Cells, Circulating

NCT02621190 2016-08-17

CARVE

Phase 2 Withdrawn

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT02065323 2015-01-19

A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT

Phase 2 Withdrawn

Neoplastic Cells, Circulating, Neoplasm Metastasis, Prostatic Neoplasms